GSK Offers $28M To Settle Suits Over Defective Paxil

By Melissa Lipman · March 2, 2009, 12:00 AM EST

GlaxoSmithKline PLC has agreed to pay $28 million to settle two proposed class actions over claims that the company's Puerto Rico plant produced defective versions of the company's antidepressant Paxil CR...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Motion

Case Information

Case Title

Simonet v. GlaxoSmithkline et al

Case Number

Court

Puerto Rico

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

March 06, 2006

Recent Articles By Melissa

March 15, 2019
UK Litigation Roundup: Here's What You Missed In London
January 11, 2019
UK Litigation Roundup: Here's What You Missed In London
November 30, 2018
UK Litigation Roundup: Here's What You Missed In London
March 09, 2018
UK Litigation Roundup: Here's What You Missed In London
November 16, 2017
FTC's Ohlhausen Sees Light At End Of Pay-For-Delay Tunnel
October 11, 2017
FDA Expert Testifies Of Unparalleled Contamination At NECC
September 20, 2017
Why A Rare Tie Vote Doesn't Foretell Roadblocks At FTC
September 10, 2017
Firms Stay The Course On London Growth Amid Brexit Haze
July 06, 2017
EU Accuses GE, Others Of Filing Misleading Info On Mergers
February 15, 2017
Anthem Wins Delaware Order To Pause Cigna Merger Breakup